Bictegravir
Records for this ingredient, by country (identity only).
ATC J05AR20 · 10 markets · 18 records
US 5 records · 3 shown of 3
Combination products containing this ingredient
GB 2 records · 2 shown of 2
AU 2 records · 1 shown of 1
Combination products containing this ingredient
- 50 mgtablet CombinationBictegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mgBiktarvy
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
ES 2 records · 2 shown of 2
CA 1 records · 1 shown of 1
Combination products containing this ingredient
- 50 mgtablet CombinationBictegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mgBiktarvy
TW 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | ES | TW | HK | JP | EU |
|---|---|---|---|---|---|---|---|---|---|
| 75 mg Combination Bictegravir 75 mg + Lenacapavir 50 mg tablet | BIXLENVO | ||||||||
| 50 mg Combination Bictegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg tablet | Biktarvy | Biktarvy | Biktarvy | Biktarvy | Biktarvy | ||||
| 30 mg Combination Bictegravir 30 mg + Emtricitabine 120 mg + Tenofovir Alafenamide 15 mg tablet | Biktarvy | Biktarvy | |||||||
| 25 mg Combination Bictegravir 25 mg + Emtricitabine 50 mg + Tenofovir Alafenamide 200 mg tablet | Biktarvy | ||||||||
| Combination Bictegravir + Emtricitabine + Tenofovir Alafenamide tablet | Biktarvy 吉他韋 膜衣錠 | ビクタルビ配合錠 | |||||||
| Combination Bictegravir + Emtricitabine + Tenofovir Alafenamide unknown | Biktarvy | Biktarvy | |||||||
| Combination Bictegravir + Bictegravir + Emtricitabine + Tenofovir + Tenofovir Alafenamide unknown | Biktarvy |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in TW · HK · JP · EU and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en TW · HK · JP · EU que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 TW · HK · JP · EU 有记录（未在本表显示）。 另有 2 個規格/劑型僅在 TW · HK · JP · EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.